Matrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial fluids from patients with rheumatoid arthritis or osteoarthritis

Annals of the Rheumatic Diseases

Volumn 59, Issue 6, 2000, Pages 455-461

  Yoshihara, Yasuo ^a   Nakamura, Hiroyuki ^b   Obata, Ken'ichi ^c   Yamada, Harumoto ^d   Hayakawa, Taro ^e   Fujikawa, Kyosuke ^a   Okada, Yasunori ^b  

^a NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

^b KEIO UNIVERSITY   (Japan)

^c FUJI CHEMICAL INDUSTRIES LTD   (Japan)

^d FUJITA HEALTH UNIVERSITY   (Japan)

^e AICHI GAKUIN UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTEINE PROTEINASE; MATRIX METALLOPROTEINASE; PHENYLMERCURIC ACETATE; SERINE PROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE; TRANSFERRIN;

ADULT; AGED; ARTICLE; ENZYME ACTIVITY; ENZYME IMMUNOASSAY; ENZYME INHIBITION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OSTEOARTHRITIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; RHEUMATOID ARTHRITIS; TRANSFERRIN BLOOD LEVEL;

ADULT; AGED; AGED, 80 AND OVER; ARTHRITIS, RHEUMATOID; FEMALE; HUMANS; KNEE JOINT; MALE; MATRIX METALLOPROTEINASES; MIDDLE AGED; OSTEOARTHRITIS; STATISTICS, NONPARAMETRIC; SYNOVIAL FLUID; TISSUE INHIBITOR OF METALLOPROTEINASES;

EID: 0008741084     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.59.6.455     Document Type: Article

References (62)

1. 1 Nagase H, Woessner JF Jr. Role of endogenous proteinases in the degradation of cartilage matrix. In: Woessner JF Jr, Howell DS, eds. Joint cartilage degradation. New York: Marcel Dekker, 1993:159-85.
2. 2 Nagase H, Okada Y. Proteinases and matrix degradation. In: Kelly WN, Harris ED Jr, Ruddy S, Sledge CB, eds. The text book of rheumatology. 5th ed. Philadelphia: Saunders, 1996: 323-41.
3. 3 Firestein GS. Etiology and pathogenesis of rheumatoid arthritis. In: Kelly WN, Harris ED Jr, Ruddy S, Sledge CB, eds. The text book of rheumatology. 5th ed. Philadelphia: Saunders, 1996:851-97.
4. 4 Sato H, Takino T, Okada Y, Cao J, Shinagawa A, Yamamoto E, et al. A matrix metalloproteinase expressed on the surface of invasive tumor cells. Nature 1994;370:61-5.
5. 5 Takino T, Sato H, Shinagawa A, Seiki M. Identification of the second membrane-type matrix metalloproteinase (MT-MMP-2) gene from a human placenta cDNA library. MT-MMPs form a unique membrane-type subclass in the MMP family. J Biol Chem 1995;270:23013-20.
6. 6 Will H, Hinzmann B. cDNA sequence and mRNA tissue distribution of novel human matrix metalloproteinase with a potential transmembrane segment. Eur J Biochem 1995; 231:602-8.
7. 7 Puente XS, Pendas AM, Liano E, Velasco G, López-Otín C. Molecular cloning of novel membrane-type matrix metalloproteinase from a human breast carcinoma. Cancer Res 1996;56:944-9.
8. 8 Pei D. Identification and characterization of the fifth membrane-type matrix metalloproteinase MT5-MMP. J Biol Chem 1999;274:8925-32.
9. 9 Pendas AM, Knäuper V, Puente XS, Llano E, Mattei M-G, Apte S, et al. Identification and characterization of a novel human matrix metalloproteinase with unique structural characteristics, chromosomal location, and tissue distribution. J Biol Chem 1997;272:4281-6.
10. 10 Bartlett JD, Simmer JP, Xue J, Margolis HC, Moreno EC. Molecular cloning and mRNA tissue distribution of a novel matrix metalloproteinase isolated from porcine enamel organ. Gene 1996;183:123-8.
11. 11 Velasco G, Pendas AM, Fueyo A, Knäuper V, Murphy G, López-Otín C. Cloning and characterization of human MMP-23, a new matrix metalloproteinase predominantly expressed in reproductive tissues and lacking conserved domains in other family members. J Biol Chem 1999;274: 4570-6.
12. 12 Uria JA, Ferrando AA, Velasco G, Frcije JMP, López-Otín C. Structure and expression in breast tumors of human TIMP-3, a new member of the metalloproteinase inhibitor family. Cancer Res 1994;54:2091-4.
13. 13 Greene J, Wang M, Liu YE, Raymond LA, Rosen C, Shi YE. Molecular cloning and characterization of human tissue inhibitor of metalloproteinase 4. J Biol Chem 1996;271: 30375-80.
14. 14 Hembry RM, Bagga MR, Reynolds JJ, Hamblen DL. Immunolocalization studies on six matrix metalloproteinases and their inhibitors, TIMP-1 and TIMP-2, in synovia from patients with osteo-and rheumatoid arthritis. Ann Rheum Dis 1995;54:25-32.
15. 15 Okada Y, Takeuchi N, Tomita K, Nakanishi I, Nagase H. Immunolocalization of matrix metalloproteinase 3 (stromelysin) in rheumatoid synovioblasts (B cell): correlation with rheumatoid arthritis. Ann Rheum Dis 1989;48: 645-53.
16. 16 Okada Y, Gonoji Y, Nakanishi I, Nagase H, Hayakawa T. Immunohistochemical demonstration of collagenase and tissue inhibitor of metalloproteinases (TIMP) in synovial lining cells of rheumatoid synovium. Virch Arch B Cell Pathol 1990;59:305-12.
17. 17 Grillet B, Dequeker J, Paemen L, Damme BV, Opdenakker G. Gelatinase B in synoviris: immunolocalization with a monoclonal antibody. Br J Rheumatol 1997;36:744-7.
18. 18 Ahrens D, Koch AE, Pope RM, Stein-Picarella M, Niedbala MJ. Expression of matrix metalloproteinase 9 (96-kd gelatinase B) in human rheumatoid arthritis. Arthritis Rheum 1996;39:1576-87.
19. 19 Stephenson ML, Goldring MB, Birkhead JR, Krane SM, Rahmsdorf H-J, Angel P. Stimulation of procollagenase synthesis parallels increases in cellular procollagenase mRNA in human articular chondrocytes exposed to recombinant interleukin-1β. Biochem Biophys Res Commun 1987;144:583-90.
20. 20 Okada Y, Shinmei M, Tanaka O, Naka K, Kimura A, Nakanishi I, et al. Localization of matrix metalloproteinase 3 (stromelysin) in osteoarthritic cartilage and synovium. Lab Invest 1992;66:680-90.
21. 21 Cole AA, Chubinskaya S, Schumacher B, Huch K, Cs-Szabo G, Yao J, et al. Chondrocyte matrix metalloproteinase-8. Human articular chondrocytes express neutrophil collagenase. J Biol Chem 1996;271: 11023-6.
22. 22 Mohtai M, Smith RL, Schurman DJ, Tsuji Y, Torti FT, Hutchinson NI, et al. Expression of 92-kDa type IV collagenase/gelatinase (gelatinase B) in osteoarthritic cartilage and its induction in normal human articular cartilage by interleukin 1. J Clin Invest 1993;92:179-85.
23. 23 Walakovits LA, Moore VL, Bhardwaj N, Gallick GS, Lark MW. Detection of stromelysin and collagenase in synovial fluid from patients with rheumatoid arthritis and posttraumatic knee injury. Arthritis Rheum 1992;35:35-42.
24. 24 Clark IM, Powell LK, Ramsey S, Hazleman BL, Cawston TE. The measurement of collagenase, tissue inhibitor of metalloproteinases (TIMP), and collagenase-TIMP complex in synovial fluids from patients with osteoarthritis and rheumatoid arthritis. Arthritis Rheum 1993;36:372-9.
25. 25 Yoshihara Y, Obata K, Fujimoto N, Yamashita K, Hayakawa T, Shimmei M. Increased levels of stromelysin-1 and tissue inhibitor of metalloproteinases-1 in serum from patients with rheumatoid arthritis. Arthritis Rheum 1995;38:969-75.
26. 26 Shinmei M, Kobayashi T, Yoshihara Y, Samura A. Significance of the levels of carboxy terminal type II procollagen peptide, chondroitin sulfate isomers, tissue inhibitor of metalloproteinases, and metalloproteinases in osteoarthritis joint fluid. J Rheumatol 1995;22(suppl 43):78-81.
27. 27 Matsuki H, Fujimoto N, Iwata K, Knäuper V, Okada Y, Hayakawa T. A one-step sandwich enzyme immunoassay for human matrix metalloproteinase 8 (neutrophil collagenase) using monoclonal antibodies. Clin Chim Acta 1996;244:129-43.
28. 28 Sopata I, Wize J, Filipowicz-Sosnowska A, Stanislawska-Biernat E, Brzezinska B, Maslinski S. Neutrophil gelatinase levels in plasma and synovial fluid of patients with rheumatic diseases. Rheumatol Int 1995;15:9-14.
29. 29 Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries HS, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
30. 30 Larsen A, Dale K, Eek M. Radiographic evaluation of rheumatoid arthritis and related conditions by standard reference film. Acta Radiol Diagn 1977;18:481-91.
31. 31 Altman R, Asch E, Bloch D, Bole G, Borenstein D, Brandt K, et al. Development of criteria for the classification and reporting of osteoarthritis: classification of osteoarthritis of the knee. Arthritis Rheum 1986;29:1039-49.
32. 32 Zang J, Fujimoto K, Iwata K, Sakai T, Okada Y, Hayakawa T. A one-step sandwich enzyme immunoassay for human matrix metalloproteinase 1 (interstitial collagenase) using monoclonal antibodies. Clin Chim Acta 1993;219:1-14.
33. 33 Fujimoto N, Mouri N, Iwata K, Ohuchi E, Okada Y, Hayakawa T. A one-step sandwich enzyme immunoassay for human matrix metalloproteinase 2 (72 kDa gelatinase type IV collagenase) using monoclonal antibodies. Clin Chim Acta 1993;221:91-103.
34. 34 Obata K, Iwata K, Okada Y, Kohrin Y, Ohuchi E, Yoshida S, et al. A one-step sandwich enzyme immunoassay for human matrix metalloproteinase 3 using monoclonal antibodies. Clin Chim Acta 1993;221:59-72.
35. 35 Ohuchi E, Azumano I, Yoshida S, Iwata K, Okada Y. A one-step sandwich enzyme immunoassay for human matrix metalloproteinase 7 (matrilysin) using monoclonal antibodies. Clin Chim Acta 1996;244:181-98.
36. 36 Fujimoto N, Hosokawa N, Iwata K, Shinya T, Okada Y, Hayakawa T. A one-step sandwich enzyme immunoassay for inactive precursor and complexed forms of human matrix metalloproteinase 9 (92 kDa gelatinase/type IV collagenase, gelatinase B) using monoclonal antibodies. Clin Chim Acta 1994;231:79-88.
37. 37 Tamei H, Azumano I, Iwata K, Yoshihara Y, Lopez-Otin C, Vizoso F, et al. One-step sandwich enzyme immunoassays for human matrix metalloproteinase 13 (collagenase-3) using monoclonal antibodies. Connect Tissue Res 1998; 30:15-22.
38. 38 Kodama S, Iwata K, Iwata H, Yamashita K, Hayakawa T, Rapid one-step sandwich enzyme immunoassay for tissue inhibitor of metalloproteinases. An application for rheumatoid arthritis serum and plasma. J Immunol Methods 1990;127;103-8.
39. 39 Fujimoto N, Zhang J, Iwata K, Shinya T, Okada Y, Hayakawa T. A one-step sandwich enzyme immunoassay for tissue inhibitors of metalloproteinase-2 using monoclonal antibodies. Clin Chim Acta 1993;220;31-45.
40. 40 Birkedal-Hansen H, Moore WGI, Bodden MK, Windsor LJ, Birkedal-Hansen B, DeCarlo A, et al. Matrix metalloproteinases: a review. Crit Rev Oral Biol Med 1993; 4:197-250.
41. 41 Okada Y, Nagase H, Harris ED Jr. A metalloproteinase from human rheumatoid synovial fibroblasts that digests connective tissue matrix components. J Biol Chem 1986;261: 14245-55.
42. 42 Nagase H. Activation mechanisms of matrix metalloproteinases. Biol Chem 1997;378:151-60.
43. 43 Beekman B, van El B, Drijfhout JW, Ronday HK, TeKoppele JM. Highly increased levels of active stromelysin in rheumatoid synovial fluid determined by a selective fluorogenic assay. FEBS Lett 1997;418:305-9.
44. 44 Mudgett JS, Hutchinson NI, Chartrain NA, Forsyth AJ, McDonnell J, Singer II, et al. Susceptibility of stromelysin 1-deficient mice to collagen-induced arthritis and cartilage destruction. Arthritis Rheum 1998;41:110-121.
45. 45 van Meurs JBJ, van Lent PLEM, Holthuysen AEM, Stoop R, Singer II, Bayne EK, et al. Expression of the MMP-induced neoepitope FVDIPEN linked to severe cartilage damage: An essential role for stromelysin in antigen-induced arthritis. Transactions of 44th Orthopaedic Research Society, Rosemont: The Orthopaedic Research Society 1998:856.
46. 46 Stoop R, van Meurs JBJ, Singer II, Bayne EK, Poole AR, Billinghurst R, et al. The collagenase cleavage site in type II collagen colocalizes with the MMP-generated aggrecan neo-epitope VDIPEN inmurine antigen induced arthritis. Transactions of 44th Orthopaedic Research Society, Rosemont: The Orthopaedic Research Society 1998:851.
47. 47 Cawston TE, McLaughlin P, Hazleman BL. Paired serum and synovial fluid values of u2-macroglobulin and TIMP in rheumatoid arthritis. Br J Rheumatol 1987;26:354-8.
48. 48 Frisch SM, Clark EJ, Werb Z. Coordinate regulation of stromelysin and collagenase genes determined with cDNA probes. Proc Natl Acad Sci USA 1987;84:2600-4.
49. 49 DiBattista JA, Pelletier J-P, Zafarullah M, Fujimoto N, Obata K, Martel-Pelletier J. Coordinate regulation of matrix metalloproteinases and tissue inhibitor of metalloproteinase expression in human synovial fibroblasts. J Rheumatol 1995;22(suppl 43):123-8.
50. 50 Zafarullah M, Pelletier J-P, Cloutier J-M, Martel-Pelletier J. Elevated metalloproteinase and tissue inhibitor of metalloproteinase mRNA in human osteoarthritic synovia. J Rheumatol 1993;20:693-7.
51. 51 Gravallese EM, Darling JM, Ladd AY, Katz JN, Glimcher LH. In situ hybridization studies of stromelysin and collagenase messenger RNA expression in rheumatoid synovium. Arthritis Rheum 1991;34:1076-84.
52. 52 McCachren SS. Expression of metalloproteinases and metalloproteinase inhibitor in human arthritic synovium. Arthritis Rheum 1991;34:1085-93.
53. 53 Nguyen Q, Mort JS, Roughley PJ. Preferential mRNA expression of stromelysin relative to procollagenase and in situ localization in human articular cartilage. J Clin Invest 1992;89:1189-97.
54. 54 Wolfe GC, MacNaul KL, Buechel FF, McDonnel J, Hoerrner LA, Lark MW, et al. Differential in vivo expression of collagenase messenger RNA in synovium and cartilage. Arthritis Rheum 1993;36:1540-7.
55. 55 Ohta S, Imai K, Yamashita K, Matsumoto T, Azumano I, Okada Y. Expression of matrix metalloproteinase 7 (matrilysin) in human osteoarthritic cartilage. Lab Invest 1998;78:79-87.
56. 56 Takizawa M, Ohuchi E, Yamanaka H, Nakamura H, Ikeda E, Ghosh P, et al. Production of tissue inhibitor of metalloproteinases-3 is selectively enhanced by calcium pentosan polysulfate in human rheumatoid synovial fibroblasts. Arthritis Rheum (in press).
57. 57 Reboul P, Pelletier J-P, Tardif G, Cloutier J-M, Martel-Pelletier J. The new collagenase, collagenase-3, is expressed and synthesized by human chondrocytes but not by synoviocytes. J Clin Invest 1996;97:2011-19.
58. 58 Wernicke D, Seyfert C, Hinzmann B, Gromnica-Ihle E. Cloning of collagenase 3 from the synovial membrane and its expression in rheumatoid arthritis and osteoarthritis. J Rheumatol 1996;23:590-5.
59. 59 Chatham WW, Heck LW, Blackburn Jr WD. Ligand-dependent release of active neutrophil collagenase. Arthritis Rheum 1990;33:228-34.
60. 60 Hanemaaijier R, Sorsa T, Konttinen YT, Ding Y, Sutinen M, Visser P, et al. Metalloproteinase-8 is expressed in rheumatoid synovial fibroblasts and endothelial cells. J Biol Chem 1997;272:31504-9.
61. 61 Cooper TW, Eizen AZ, Stricklin GP, Welgus HG. Platelet-derived collagenase inhibitor: characterization and subcellular localization. Proc Natl Acad Sci USA 1985;82: 2779-83.
62. 62 Farr M, Wain WA, Salmon M, Hollywell CA, Bucon PA. Platelets in the synovial fluid of patients with RA. Rheumatol Int 1984;4:13-17.